Synlett 2008(1): 116-118  
DOI: 10.1055/s-2007-1000837
LETTER
© Georg Thieme Verlag Stuttgart · New York

Synthesis of Sulfoximidoyl-Substituted Triazoles by Huisgen 1,3-Dipolar Cycloaddition

Bernhard Fügera, Genia Skluteb, Ilan Marekb, Gae Young Bolma, Carsten Bolm*a
a Institut für Organische Chemie, RWTH Aachen, Landoltweg 1, 52056 Aachen, Germany
Fax: +49(241)8092391; e-Mail: Carsten.Bolm@oc.rwth-aachen.de;
b The Mallat Family Laboratory of Organic Chemistry, Schulich Faculty of Chemistry and The Lise Meitner-Minerva Center for Computational Quantum Chemistry, Technion-Israel Institute of Technology, Haifa 32 000, Israel
Weitere Informationen

Publikationsverlauf

Received 11 October 2007
Publikationsdatum:
11. Dezember 2007 (online)

Abstract

The reaction of alkynyl sulfoximines with in situ prepared organic azides in water-dichloromethane under reflux affords sulfoximidoyl-substituted triazoles by Huisgen 1,3-dipolar cycloaddition.

    References and Notes

  • For selected recent contributions, see:
  • 1a Reggelin M. Kuehl J. Kaiser JP. Buehle P. Synthesis  2006,  2224 
  • 1b Rajender A. Gais H.-J. Org. Lett.  2007,  9:  579 
  • 1c Adrien A. Gais H.-J. Koehler F. Runsink J. Raabe G. Org. Lett.  2007,  9:  2155 
  • 2a Bolm C. Müller D. Dalhoff C. Hackenberger CPR. Weinhold E. Bioorg. Med. Chem. Lett.  2003,  13:  3207 
  • 2b Cho GY. Okamura H. Bolm C. J. Org. Chem.  2005,  70:  2346  and references therein
  • Reviews:
  • 3a Harmata M. Chem. Abstr.  2003,  16:  660 
  • 3b Okamura H. Bolm C. Chem. Lett.  2004,  33:  482 
  • Reviews:
  • 4a Johnson CR. Acc. Chem. Res.  1973,  6:  341 
  • 4b Pyne SG. Sulfur Rep.  1992,  12:  57 
  • 4c Reggelin M. Zur C. Synthesis  2000,  1 
  • 4d Bolm C. In Asymmetric Synthesis with Chemical and Biological Methods   Enders D. Jäger K.-E. Wiley-VCH; Weinheim: 2007.  p.149 
  • For a selection of recent patents emphasizing this point, see:
  • 5a Luecking U, Krüger M, Jautelat R, and Siemeister G. inventors; WO 037800  A1.  ; Schering AG
  • 5b Luecking U, Siemeister G, and Jautelat R. inventors; WO 099974  A1.  ; Schering AG
  • 5c Luecking U, Nguyen D, von Bonin A, von Ahsen O, Krueger M, Briem H, Kettschau H, Prien O, Mengel A, Krolikiewicz K, Boemer U, Bothe U, and Hartung I. inventors; WO 071455  A1.  ; Schering AG
  • 5d Luecking U. inventors; EP 1 710 246  A1.  ; Schering AG
  • 5e Luecking U, Bader B, and Siemeister G. inventors; EP 1 803 723  A1.  ; Bayer Schering Pharma
  • 5f Shetty SJ, Patel GD, Lohray BB, Lohray VB, Chakrabarti G, Chatterjee A, Jain MJ, and Patel PR. inventors; WO 077574  A2.  ; Cadila Healthcare Limited
  • 5g Zhu Y, Rogers RB, and Huang YX. inventors; US 228027  A1.  ; Dow Agroscience
  • 5h Jeanguenat A, and O’Sullivan AC. inventors; WO 032462  A1.  ; Syngenta
  • 5i Jeanguenat A, and O’Sullivan AC. inventors; WO 061200  A1.  ; Syngenta
  • 5j Plant A, Boehmer JE, and Peace AL. inventors; WO 037945  A1.  ; Syngenta
  • 5k Kajita S, Ohmura H, Akashi M, Kojima S, Satoh A, and Tomida K. inventors; WO  052849.  ; Nippon Soda Co., Ltd
  • 6 Garcia Mancheño O. Bolm C. Org. Lett.  2006,  8:  2349 
  • 7 Garcia Mancheño O. Bistri O. Bolm C. Org. Lett.  2007,  9:  3809 
  • For regioselective syntheses and applications of triazoles, see:
  • 8a Butler RN. In Comprehensive Heterocyclic Chemistry   Vol. 4:  Katritzky AR. Rees CW. Scriven EFV. Pergamon; Oxford UK: 1996.  p.121 
  • 8b Yoo EJ. Ahlquist M. Kim SH. Bae I. Fokin VV. Sharpless KB. Chang S. Angew. Chem. Int. Ed.  2007,  46:  1730 
  • Reviews:
  • 8c Bock VD. Hiemstra H. van Maarseveen JH. Eur. J. Org. Chem.  2006,  51 
  • 8d Lutz JF. Angew. Chem. Int. Ed.  2007,  46:  1018 
  • 9 Sklute G. Bolm C. Marek I. Org. Lett.  2007,  9:  1259 
  • 10a Lacôte E. Amatore M. Fensterbank L. Malacria M. Synlett  2002,  116 
  • 10b Leca D. Song K. Amatore M. Fensterbank L. Lacote E. Malacria M. Chem. Eur. J.  2004,  10:  906 
  • For recently developed alternative imination protocols, see:
  • 11a Okamura H. Bolm C. Org. Lett.  2004,  6:  1305 
  • 11b Cho GY. Bolm C. Org. Lett.  2005,  7:  4983 
  • 11c Cho GY. Bolm C. Tetrahedron Lett.  2005,  46:  8007 
  • 11d

    Refs 6 and 7.

12

In the reactions reported here, racemic sulfoximines were used.

13

The interactions between the benzylic hydrogens and the hydrogens of the alkyl or alkoxy chain in the 1H-NOESY spectra also confirmed the molecular structures of triazole derivatives 3b-e,g,h. Although present in the crude product mixtures, the other regioisomers (triazoles 5) could never be obtained in pure form (Figure [1] ).

Figure 1

14

General Procedure for the Cycloaddition ReactionUnder vigorous stirring a mixture of NaN3 (12 equiv) and the corresponding bromide (15 equiv) was heated to reflux in H2O (0.7 M) for 1 h. Then, a solution of sulfoximine 4 (1 equiv) in CH2Cl2 (0.08 M) was added dropwise. After 3 h at 100 °C under reflux and stirring, the product was extracted with CH2Cl2 and purified by flash column chromatography. As representative example, the analytical data for 1-benzyl-5-butyl-4-(N-tosyl)-(4-methylphenylsulfonimidoyl)-1H-1,2,3-triazole (3a) obtained from the reaction of sulfoximine 4a with benzyl azide are given. Colorless oil (68%); chromatography: EtOAc-pentane (1:3). 1H NMR (400 MHz, CDCl3): δ = 0.79 (t, J = 7.0 Hz, 3 H), 1.21-1.29 (m, 4 H), 2.37 (s, 3 H), 2.41 (s, 3 H), 2.76-2.85 (m, 1 H), 2.93-3.02 (m, 1 H), 5.44 (d, J = 15.5 Hz, 1 H), 5.49 (d, J = 15.5 Hz, 1 H), 7.14-7.18 (m, 2 H), 7.20 (d, J = 8.0 Hz, 2 H), 7.31-7.35 (m, 5 H), 7.80 (d, J = 8.3 Hz, 2 H), 7.98 (d, J = 8.5 Hz, 2 H). 13C NMR (100 MHz, CDCl3): δ = 13.6 (CH3), 21.5 (CH3), 21.7 (CH3), 22.7 (CH2), 23.0 (CH2), 30.5 (CH2), 52.5 (CH2), 126.5 (CH), 127.2 (CH), 128.2 (CH), 128.7 (CH), 129.0 (2 × CH), 129.9 (CH), 133.5 (C), 135.2 (C), 140.4 (C), 141.4 (C), 141.9 (C), 142.6 (C), 145.4 (C). IR (CHCl3): ν = 2959 (m), 1454 (m), 1318 (m), 1243 (m), 1096 (s), 1018 (m), 757 (s), 540 (m). MS (CI): m/z (relative intensity) = 523 (6) [M + H]+. Anal. Calcd for C27H30N4S2O3: C, 62.04; H, 5.79; N, 10.72. Found: C, 62.06; H, 5.81; N, 11.14.